Ozempic, WeightWatchers
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Ozempic maker's CEO blames insurance companies for weight-loss drug prices
The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss drugs in the U.S. during a congressional testimony on Tuesday. Why it matters: Lars Fruergaard Jørgensen,
WeightWatchers CEO to Step Down After 2 Years
The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and Wegovy.
WeightWatchers CEO Sima Sistani steps down after over 2-year stint
WW International, also known as WeightWatchers, said on Friday CEO Sima Sistani was stepping down and that insider Tara Comonte would succeed her on an interim basis. During Sistani's two-and-a-half-year tenure,
WeightWatchers is struggling in the weight loss drug era — and now the CEO is out
International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board member and the former CEO of Shake Shack (SHAK), who was appointed as interim chief executive effective immediately.
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year-old company — famous for in-person meetings and portion control — to buy a telehealth platform that connected patients with doctors who can prescribe the popular obesity medications.
Ozempic, James Corden
She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
Ozempic May Decrease Opioid Overdose Risk, New Research Suggests
Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...
Weight Loss Is Only The Beginning For Ozempic: The Latest Discovery Could Save Countless Lives
A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes
Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.
Benefits Pro55m
Employer plans face GLP-1 anti-obesity drug rebate threats
About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...
Novo CEO Blames Ozempic’s High Cost on Drug Middlemen’s Tactics
Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of ...